There has been an exponential
increase in the number of
systematic reviews and metaanalyses
in the past 40 or so years,
according to Giovanni Domenico
Tebala from Noble’s Hospital in the
UK in Medical Hypotheses.
His concern with the trend is
that randomised controlled trials
are harder and more expensive
than meta-analyses and systematic
reviews which can be relatively
easy to perform but can still get
published in high impact journals.
Unless we can invert this trend,
he writes, we will have fewer
raw data upon which to draw
conclusions.
CLICK HERE for the abstractThe above article was sent to subscribers in Pharmacy Daily's issue from 13 Aug 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Aug 15
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
THE University of South Australia has released a new study to help healthcare workers better support women with persistent pelvic pain, including symptoms that are suggestive of gynaecological, lower urinary tract, bowel, sexual, and pelvic floor dysfunction.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.